| Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study JJ Eron, B Clotet, J Durant, C Katlama, P Kumar, A Lazzarin, ... The Journal of infectious diseases 207 (5), 740-748, 2013 | 319 | 2013 |
| The importance of social networks in their association to drug equipment sharing among injection drug users: a review P De, J Cox, JF Boivin, RW Platt, AM Jolly Addiction 102 (11), 1730-1739, 2007 | 206 | 2007 |
| Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis DHS Tan, MW Hull, D Yoong, C Tremblay, P O’byrne, R Thomas, J Kille, ... CMAJ 189 (47), E1448-E1458, 2017 | 145 | 2017 |
| Cohort profile: the Canadian HIV–hepatitis C co-infection cohort study MB Klein, S Saeed, H Yang, J Cohen, B Conway, C Cooper, P Côté, ... International journal of epidemiology 39 (5), 1162-1169, 2010 | 101 | 2010 |
| How generalizable are the results from trials of direct antiviral agents to people coinfected with HIV/HCV in the real world? S Saeed, EC Strumpf, SL Walmsley, K Rollet-Kurhajec, N Pick, ... Clinical Infectious Diseases 62 (7), 919-926, 2016 | 81 | 2016 |
| Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review P De, E Roy, JF Boivin, J Cox, C Morissette Journal of viral hepatitis 15 (4), 279-292, 2008 | 73 | 2008 |
| Association between food insecurity and HIV viral suppression: a systematic review and meta-analysis W Aibibula, J Cox, AM Hamelin, T McLinden, MB Klein, P Brassard AIDS and behavior 21 (3), 754-765, 2017 | 71 | 2017 |
| Circulating (1→ 3)-β-D-glucan is associated with immune activation during human immunodeficiency virus infection V Mehraj, R Ramendra, S Isnard, FP Dupuy, R Ponte, J Chen, I Kema, ... Clinical Infectious Diseases 70 (2), 232-241, 2020 | 65 | 2020 |
| Risk factors for hepatitis C virus reinfection after sustained virologic response in patients coinfected with HIV J Young, C Rossi, J Gill, S Walmsley, C Cooper, J Cox, ... Clinical Infectious Diseases 64 (9), 1154-1162, 2017 | 65 | 2017 |
| Include them and they will tell you: Learnings from a participatory process with youth JAM MacDonald, AJ Gagnon, C Mitchell, G Di Meglio, JE Rennick, J Cox Qualitative Health Research 21 (8), 1127-1135, 2011 | 61 | 2011 |
| Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts W Cao, V Mehraj, B Trottier, JG Baril, R Leblanc, B Lebouche, J Cox, ... Clinical Infectious Diseases 62 (2), 250-257, 2016 | 60 | 2016 |
| HIV and hepatitis C virus coinfection in C anada: challenges and opportunities for reducing preventable morbidity and mortality MB Klein, KC Rollet, S Saeed, J Cox, M Potter, J Cohen, B Conway, ... HIV medicine 14 (1), 10-20, 2013 | 56 | 2013 |
| Asking to listen: towards a youth perspective on sexual health education and needs JA MacDonald, AJ Gagnon, C Mitchell, G Di Meglio, JE Rennick, J Cox Sex Education 11 (4), 443-457, 2011 | 56 | 2011 |
| Food insecurity and low CD4 count among HIV-infected people: a systematic review and meta-analysis W Aibibula, J Cox, AM Hamelin, H Mamiya, MB Klein, P Brassard AIDS care 28 (12), 1577-1585, 2016 | 54 | 2016 |
| Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montreal É Roy, É Nonn, N Haley, J Cox International journal of drug policy 18 (5), 397-405, 2007 | 54 | 2007 |
| Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review N Kronfli, B Linthwaite, F Kouyoumdjian, MB Klein, B Lebouché, ... International Journal of Drug Policy 57, 95-103, 2018 | 53 | 2018 |
| Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada S Saeed, EC Strumpf, EEM Moodie, J Young, R Nitulescu, J Cox, A Wong, ... Journal of the International AIDS Society 20 (3), e25013, 2017 | 49 | 2017 |
| Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users J Cox, P De, C Morissette, C Tremblay, R Stephenson, R Allard, L Graves, ... Social Science & Medicine 66 (2), 211-220, 2008 | 48 | 2008 |
| Cretaceous Viking Formation of the Western Canada Sedimentary Basin GE Reinson, WJ Warters, J Cox, PR Price, G Mossop, I Shetsen Geological Atlas of the Western Canada Sedimentary Basin. GD Mossop and I …, 1994 | 48 | 1994 |
| Correlates of unprotected anal sex at last sexual episode: analysis from a surveillance study of men who have sex with men in Montreal G Lambert, J Cox, TS Hottes, C Tremblay, LR Frigault, M Alary, J Otis, ... AIDS and Behavior 15 (3), 584-595, 2011 | 45 | 2011 |
